RxDoctor Payments Data

Emily Cummins, NP

Family · Jasper, GANPI 1205078730

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (44.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Curonix LLC accounts for 62.6% of it on its own, with 38 other manufacturers making up the rest. Among family clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$30,415in general payments, 2019–2025

Across 320 payments — averaging $95.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Curonix LLC$19K
  • Saluda Medical Americas, Inc.$2K
  • Nevro Corp.$2K
  • Biotronik NRO, Inc.$2K
  • Vertos Medical, Inc.$1K
  • Abbott$811
  • plus $3K from 33 others
$40in research payments, 2019–2025

Across 1 payment — averaging $39.53 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Saluda Medical Americas, Inc.$40

What the payments were for

  • Consulting fees$13,63145%
  • Travel & lodging$6,87723%
  • Food & beverage$9,90033%
  • Education$70%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$30,415 in reported general payments places this provider in the 95th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Medicare billing

Part B allowed, 2024
$236,658
Medicare patients
405
Services billed
5,553

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Aimovig AutoinjectorErenumab-Aooe15$10,914
Buprenorphine43$8,528
MovantikNaloxegol Oxalate17$8,408
ButransBuprenorphine17$5,746
SavellaMilnacipran Hcl12$5,563
Gabapentin355$4,486
Pregabalin145$2,766
Tramadol Hcl294$2,234
Buprenorphine Hcl41$813
Nortriptyline Hcl70$743
Cyclobenzaprine Hcl113$720
Methocarbamol89$718
Duloxetine Hcl64$652
Tizanidine Hcl117$636
Celecoxib29$385

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Redhill Biopharma Inc.Movantik$19$8,40817 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,258 family providers in Georgia.

Other family in Jasper

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →